Because the AKR1B10 expression was pertinently associated with oncogenic properties (Figure 4), it was postulated that the cellular sensitivity of NSCLC might be modulated by AKR1B10. This evidence concerns the gene AKR1B10 and non-small cell lung carcinoma.